TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?

por Molica, Matteo, Mazzone, Carla, Niscola, Pasquale, de Fabritiis, Paolo
Publicado 2021

CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML

por Molica, Matteo, Perrone, Salvatore, Mazzone, Carla, Cesini, Laura, Canichella, Martina, de Fabritiis, Paolo
Publicado 2022

Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation

por Niscola, Pasquale, Grazia, Carmen Di, Mazzone, Carla, Tolu, Barbara, de Fabritiis, Paolo, Angelucci, Emanuele
Publicado 2019

CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin

por Molica, Matteo, Perrone, Salvatore, Mazzone, Carla, Niscola, Pasquale, Cesini, Laura, Abruzzese, Elisabetta, de Fabritiis, Paolo
Publicado 2021

PB2033: ADVANCED CHRONIC MYELOMONOCYTIC LEUKEMIA IN ELDERLY AND FRAIL PATIENTS MANAGED BY AZACITIDINE IN THE FIELD OF CLINICAL PRACTICE.

por Niscola, Pasquale, Mazzone, Carla, Ardu, Nicolina Rita, Cesini, Laura, Giovannini, Marco, Fratoni, Stefano, de Fabritiis, Paolo
Publicado 2023

Case Report: Very Late, Atypical Extra-Medullary Relapse in a Patient With Acute Promyelocytic Leukemia (APL) Rescued With a Transplant-Free Approach

por Molica, Matteo, Mazzone, Carla, Ottone, Tiziana, Niscola, Pasquale, Abruzzese, Elisabetta, Fratoni, Stefano, Voso, Maria Teresa, de Fabritiis, Paolo
Publicado 2021

Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter R...

por Molica, Matteo, Mazzone, Carla, Niscola, Pasquale, Carmosino, Ida, Di Veroli, Ambra, De Gregoris, Cinzia, Bonanni, Fabrizio, Perrone, Salvatore, Cenfra, Natalia, Fianchi, Luana, Piccioni, Anna Lina, Spadea, Antonio, Luzi, Giovanni, Mengarelli, Andrea, Cudillo, Laura, Maurillo, Luca, Pagano, Livio, Breccia, Massimo, Rigacci, Luigi, De Fabritiis, Paolo
Publicado 2022

P372: CMV REACTIVATIONS/INFECTIONS IN PH+ ALL PATIENTS TREATED WITH DASATINIB WITH OR WITHOUT BLINATUMOMAB. A RETROSPECTIVE MULTICENTER CAMPUS ALL STUDY

por Annunziata, Mario, Lunghi, Monia, Giglio, Fabio, Leoncin, Matteo, Dargenio, Michelina, Bonifacio, Massimiliano, De Gobbi, Marco, Mazzone, Carla, Agrippino, Roberta, Lazzarotto, Davide, Roncoroni, Elisa, Defina, Marzia, Fracchiolla, Nicola, Guolo, Fabio, Ilaria Del Principe, Maria, Scappini, Barbara, Mulè, Antonino, Ciccone, Maria, Pasciolla, Crescenza, Ferrara, Felicetto, Pizzolo, Giovanni, Foà, Robin, Chiaretti, Sabina
Publicado 2023

COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL report

por Chiaretti, Sabina, Bonifacio, Massimiliano, Agrippino, Roberta, Giglio, Fabio, Annunziata, Mario, Curti, Antonio, Del Principe, Maria Ilaria, Salutari, Prassede, Sciumè, Mariarita, Delia, Mario, Armenio, Marco, Mancini, Valentina, Mulè, Antonino, Grimaldi, Francesco, Rege-Cambrin, Giovanna, Santoro, Lidia, Lussana, Federico, Chiusolo, Patrizia, Pasciolla, Crescenza, Scattolin, Anna Maria, Cerrano, Marco, Ciccone, Maria, Defina, Marzia, Forghieri, Fabio, Mazzone, Carla, Piccini, Matteo, Ferrara, Felicetto, Pizzolo, Giovanni, Foà, Robin
Publicado 2022

ACUTE Lymphoblastic Leukemia (ALL) and COVID-19 Infection. a Campus ALL Report

por Chiaretti, Sabina, Bonifacio, Massimiliano, Agrippino, Roberta, Annunziata, Mario, Candoni, Anna, Marco, Cerrano, Cedrone, Michele, Ciccone, Maria, Chiusolo, Patrizia, Curti, Antonio, Dargenio, Michelina, Defina, Marzia, Delia, Mario, Del Principe, Maria Ilaria, Endri, Mauro, Fava, Carmen, Forghieri, Fabio, Fiorentini, Alessandro, Giglio, Fabio, Grimaldi, Francesco, Guolo, Fabio, Lamanda, Michela, Lunghi, Monia, Lussana, Federico, Mancini, Valentina, Mazzone, Carla, Mulè, Antonino, Pasciolla, Crescenza, Piccini, Matteo, Rege Cambrin, Giovanna, Salutari, Prassede, Santoro, Lidia, Scattolin, Anna Maria, Sciumè, Mariarita, Todisco, Elisabetta, Ferrara, Felicetto, Pizzolo, Giovanni, Foà, Robin
Publicado 2021